Search concepts
|
Selected Filters
|
- 1,000 - 1,050 out of 1,428 results
Search results
-
Induction of autosis to overcome resistance in adoptive cell therapy for solid tumors
4/1/23 → 3/31/28
Project: Federal Funding Agencies
-
Cardiac Autonomic Activation In Atrial Fibrillation Triggers And Substrate
4/1/23 → 3/31/28
Project: Federal Funding Agencies
-
Transforming Curiosity into Donation: Validating a Risk Prediction Index to Detect and Prevent Drop-Out in Potential Living Kidney Donors who are Racial/Ethnic Minorities
9/1/23 → 5/31/28
Project: Federal Funding Agencies
-
-
Dual targeting of PI3K and NOS pathways in Metaplastic Breast Cancer (MBC)
7/8/23 → 6/30/28
Project: Federal Funding Agencies
-
PK-RNN-V - Deep-Learning Based Pharmacokinetic Model for Vancomycin
9/21/23 → 7/31/28
Project: Federal Funding Agencies
-
Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells
8/1/23 → 7/31/28
Project: Federal Funding Agencies
-
-
Spinal Neuromodulation to Promote Physiologic and Molecular Plasticity in the Injured Spinal Cord
9/20/23 → 8/31/28
Project: Federal Funding Agencies
-
Landscapes for Cell State Transition Leveraging by Single-Cell Multi-Omics
9/1/23 → 8/31/28
Project: Federal Funding Agencies
-
?Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response?
9/19/23 → 8/31/28
Project: Federal Funding Agencies
-
Quantitation of nutrient metabolism in brain tumor patients using advanced 13C isotopomer technology
9/1/23 → 8/31/28
Project: Federal Funding Agencies
-
Role of lipid metabolism in CD8+ T cell ferroptosis
9/19/23 → 8/31/28
Project: Federal Funding Agencies
-
-
Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors
1/1/24 → 12/31/28
Project: Federal Funding Agencies
-
Daratumab to Enhance therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
4/30/19 → 4/29/29
Project: Non Profit
-
4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
8/1/23 → 7/31/30
Project: Federal Funding Agencies
-
A Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in premenopausal Women at High Risk for Breast Cancer, Phase IIB
6/29/12 → 3/22/37
Project: Federal Funding Agencies
-
Gaining Efficacy Long Term:Hydrosoft and Emerging New Embolic Coil (Gel-the-nec)
1/18/10 → 6/4/37
Project: Non Profit
-
Prospective multi-center randomized double-blind trial to assess the effectiveness and safety of 12 vs 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous coronary intervention (PCI) with either drug-eluting (DES) or bar
Harvard Clinical Research Institute
6/30/10 → 11/14/37
Project: Non Profit
-
TrialNet Natural History Study of the Development of Type 1 Diabetes
9/13/10 → 1/28/38
Project: Federal Funding Agencies
-
Escalating Clopidogrel by Involving a Genetic Strategy (ELEVATE-TIMI 56)
11/10/10 → 3/27/38
Project: Non Profit
-
A Phase II/III Trial of Neoadjuvant FOLFOX w/ Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection w/ Total Mesorectal Excisio
Bernicker, E. H., Darcourt, J. & Singh, M.
6/11/13 → 6/10/38
Project: Non Profit
-
-
-
PHASE III RANDOMIZED STUDY OF SORAFENIB PLUS DOXORUBICIN VERSUS SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Bernicker, E. H., Darcourt, J. & Singh, M.
8/13/13 → 8/12/38
Project: Non Profit
-
-
RTOG-0834; RTOG-0913; RTOG-0929
Radiation Therapy Oncology Group
8/10/11 → 12/25/38
Project: Federal Funding Agencies
-
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination withIntravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVACancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Zaid, T., Butler, E. B., Darcourt, J., Farach, A. M., Kamat, A. A., Shkedy, C., Singh, M. & Suri, A.
3/1/14 → 2/28/39
Project: Non Profit
-
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study:A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with orwithout Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients withDefici
Abdelrahim, M., Bernicker, E. H., Darcourt, J., Heyne, K. & Singh, M.
3/1/14 → 2/28/39
Project: Non Profit
-
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab (IND #134427) Versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab in P
Kamat, A. A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.
3/1/14 → 2/28/39
Project: Non Profit
-
-
EAY131 - Molecular Analysis for Therapy Choice (MATCH)
Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Kamat, A. A., Pingali, S. R. & Singh, M.
9/20/16 → 9/20/41
Project: Federal Funding Agencies
-
A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OFASPIRIN AS ADJUVANT THERAPY FOR HER2 NEGATIVE BREAST CANCER: THE ABCTRIAL
Arentz, C., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
12/8/16 → 12/7/41
Project: Non Profit